Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Possible Heart Risk With Testosterone Spurs Debate on Use
Bloomberg
Tuesday, September 16, 2014 - 9:24am
tags:
testosterone, Eli Lilly, Auxilium, Rextoro, Clarus Therapeutics
Lawyer grills DePuy executive over safety studies for Pinnacle hips
Yahoo/Reuters
Tuesday, September 16, 2014 - 9:22am
tags:
JNJ, DePuy, Pinnacle Hip, devices
Lilly to Pay AstraZeneca $500 Million in Alzheimer’s Push
Bloomberg
Tuesday, September 16, 2014 - 9:21am
tags:
Eli Lilly, AstraZeneca, Alzheimer's disease, BACE inhibitors, AZD3293
Xtandi field force to increase by 50% for market-share battle with Zytiga
Fierce Pharma Marketing
Monday, September 15, 2014 - 7:30pm
tags:
Xtandi, Medivation, Astellas, hirings, JNJ, Zytiga
Arena Down On The Back Of Weight-Loss Drug Failure
Bidness Etc.
Monday, September 15, 2014 - 7:28pm
tags:
Arena Pharmaceuticals, obesity, Belviq
Gilead Deal to Sell Sovaldi in Poor Countries Meets Criticism
WSJ Pharmalot
Monday, September 15, 2014 - 7:21pm
tags:
Gilead Sciences, drug pricing, hepatitis C, Sovaldi
NY bid to halt Alzheimer's drug swap
Yahoo/AP
Monday, September 15, 2014 - 7:20pm
tags:
Alzheimer's disease, Namenda, Namenda XR, Forest Labs, Actavis
These Two Companies Could Be Pfizer’s Top Targets
Barron's
Monday, September 15, 2014 - 4:34pm
tags:
Pfizer, M&A, Actavis, AstraZeneca
Long-delayed Merck osteoporosis drug meets goal in study
Yahoo/Reuters
Monday, September 15, 2014 - 4:31pm
tags:
Merck, osteoporosis, Odanacatib
Baxter and Halozyme sway the FDA after a painful rejection
Fierce Biotech
Monday, September 15, 2014 - 11:46am
tags:
Baxter International, Halozyme, FDA, HyQvia
Avanir's Over-Priced Cough Syrup Touted For Role in Alzheimer's Agitation
TheStreet.com
Monday, September 15, 2014 - 11:37am
tags:
Avanir, Alzheimer's disease, AVP-923
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks
24/7 Wall St
Monday, September 15, 2014 - 11:36am
tags:
hepatitis C, Gilead Sciences, AbbVie, Achillion, Merck, Sovaldi, Idenix
Roche's Genentech triggers its PhIII program for blockbuster AMD contender
Fierce Biotech
Monday, September 15, 2014 - 10:51am
tags:
Roche, Genentech, AMD, Chroma, Spectri
Shire eating disorder drug gets U.S. priority review
Yahoo/Reuters
Monday, September 15, 2014 - 10:27am
tags:
Shire, binge eating disorder, Vyvanse
EU to decide on $52 bln AbbVie, Shire deal by Oct. 16
Yahoo/Reuters
Monday, September 15, 2014 - 10:24am
tags:
Europe, AbbVie, Shire
Big Pharma: $100 Billion In Future Sales Expected
Bidness Etc.
Monday, September 15, 2014 - 10:10am
tags:
Bristol-Myers Squibb, Merck, GSK, Novo Nordisk, Sanofi, Novartis, Pfizer, Biogen Idec, Roche
Lung cancer vaccine to enter clinical trials
Pharmaphorum
Monday, September 15, 2014 - 10:02am
tags:
lung cancer, vaccines, Asterias, AST-VAC2, non-small cell lung cancer
Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure
Yahoo
Monday, September 15, 2014 - 9:21am
tags:
Amgen, ivabradine, chronic heart failure
Selling Obesity Drugs to Americans Shouldn't Be This Hard
Bloomberg/Businessweek
Monday, September 15, 2014 - 9:18am
tags:
obesity, Orexigen, Contrave, Qsymia, Belviq, Arena Pharmaceuticals, Eisai
Ackman’s Pershing Fund Seeks to Raise $2 Billion in IPO
Bloomberg
Monday, September 15, 2014 - 9:16am
tags:
Bill Ackman, IPOs, Pershing Square, Allergan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.